2019-01-01 00:00:00
The oral microbiome of early stage Parkinson’s disease and its relationship with functional measures of motor and non-motor function
Categories
View AllConditions
View AllDefinitions
View All
Amsel’s Criteria
Blood-Brain Barrier (BBB)
Bradford Hill Criteria
Coelomic Metaplasia Theory
Drug Repurposing
Endometriomas
Environmental Theory of Endometriosis
Estrobolome
Estrogen
Estrogen Receptors (ER)
Facultative Anaerobes
Fecal Microbiota Transplantation (FMT)
Genetic and Epigenetic Theory of Disease
Gram-Negative Bacteria
Idiopathic
Guides & Resources
View AllInterventions
View AllMicrobes
View AllMetals
View AllResearch Feeds
View All
Diagnosis of the menopause: NICE guidance and quality standards
Structured Exercise Benefits in Euthyroid Graves’ Disease: Improved Capacity, Fatigue, and Relapse
Gut microbiota modulation: a narrative review on a novel strategy for prevention and alleviation of ovarian aging
Dietary Intake and Ovarian Cancer Risk: A Systematic Review
Maternal Iron Deficiency Anemia Affects Postpartum Emotions and Cognition
Evidence for the Use of Complementary and Alternative Medicine for Pelvic Inflammatory Disease: A Literature Review
Prevalence of hot flushes and night sweats around the world: a systematic review
Vaginal microbiome of women with premature ovarian insufficiency: a descriptive cross-sectional study
Exercise for dysmenorrhoea
Black cohosh (Cimicifuga spp.) for menopausal symptoms.
Nifedipine for primary dysmenorrhoea
Drugs for the treatment of menopausal symptoms.
Does Physical Exercise Lower Endometriosis Risk? Systematic Review Insights
The Effects of Toxic Heavy Metals Lead, Cadmium and Copper on the Epidemiology of Male and Female Infertility
The role of probiotics in improving menstrual health in women with primary dysmenorrhoea
Karen Pendergrass, Standards Team
About
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.
Recent Posts
2019-01-01 00:00:00
Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson’s disease2019-01-01 00:00:00
Gut Microbiota Differs Between Parkinson’s Disease Patients and Healthy Controls in Northeast China2019-01-01 00:00:00
Altered Gut Microbiome in Parkinson’s Disease and the Influence of Lipopolysaccharide in a Human α-Synuclein Over-Expressing Mouse Model2019-01-01 00:00:00
Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota2019-01-01 00:00:00
Analysis of the Gut Microflora in Patients With Parkinson’s Disease2019-01-01 00:00:00
Diversity of vaginal microbiome and metabolome during genital infections2019-01-01 00:00:00
The Endobiota Study: Comparison of Vaginal, Cervical and Gut Microbiota Between Women with Stage 3/4 Endometriosis and Healthy ControlsThis study reveals distinct microbiome shifts in the vaginal, cervical, and gut microbiota of women with stage 3/4 endometriosis. The absence of Atopobium and elevated Gardnerella in reproductive sites suggest immune dysregulation, while Shigella dominance in stool samples correlates with bowel involvement, highlighting potential diagnostic biomarkers.
2019-01-01 00:00:00
Antibiotic therapy with metronidazole reduces endometriosis disease progression in mice: a potential role for gut microbiotaThis study shows that antibiotic therapy with metronidazole reduces endometriotic lesion growth and inflammation in mice by targeting the gut microbiota, particularly Bacteroidetes. Findings suggest that microbiota-targeted treatments may offer new therapeutic avenues for endometriosis management.
2019-01-01 00:00:00
Molecular detection of microbial colonization in cervical mucus of women with and without endometriosisThis study identifies intrauterine microbial colonization in endometriosis, with enriched Streptococcaceae, Staphylococcaceae, and Enterobacteriaceae. RHa therapy exacerbated microbial imbalances, highlighting potential therapeutic targets for managing inflammation and infection in endometriosis. Findings suggest microbial modulation may enhance treatment outcomes.